Robert E. Sobol, M.D. has pioneered the development of novel biological therapies.  He was one of the first physicians to treat patients with monoclonal antibodies and gene therapy. Dr. Sobol is an internationally recognized expert in the fields of molecular cancer therapies and biomarkers. Dr. Sobol led the research teams responsible for the first experimental gene therapies for the treatment of brain tumors and colon carcinoma.

Dr. Sobol has served in the American Society of Gene and Cell Therapy as the Chair of both the Cancer Gene and Cell Therapy and the Bio Industry Liaison Committees. He is a member of several medical and scientific societies and was appointed to the Clinical Program Review Committee of the National Cancer Institute of the National Institutes of Health. He was the founding Editor-in-Chief of Cancer Gene Therapy, a Nature Publishing Group journal.

Dr. Sobol received a B.A. in Philosophy from Boston University and a M.D. from The Chicago Medical School. He subsequently trained at the University of Southern California Medical Center and at the University of California, San Diego and received Board Certifications in Internal Medicine and Medical Oncology.